|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 4/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
164,320,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.6539 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ViewRay designs, manufactures and markets the ViewRay MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary magnetic resonance imaging (MRI) system to address the challenges and clinical workflow for radiation oncology. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic-quality MRI with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. Co.'s generations of the MRIdian are: the MRIdian with Cobalt-60 based radiation beams and MRIdian Linac, with linear accelerator or linac based radiation beams.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
55,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$204,826 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
13,487,227 |
13,529,227 |
| Total Sell Value |
$0 |
$0 |
$844,275 |
$1,017,735 |
| Total People Sold |
0 |
0 |
8 |
9 |
| Total Sell Transactions |
0 |
0 |
11 |
12 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-07 |
4 |
OE |
$0.75 |
$93,750 |
D/D |
125,000 |
779,368 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-03 |
4 |
S |
$4.13 |
$173,460 |
D/D |
(42,000) |
654,368 |
|
90% |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-03 |
4 |
OE |
$0.75 |
$31,500 |
D/D |
42,000 |
696,368 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
D |
$4.12 |
$163,564 |
D/D |
(39,700) |
654,368 |
|
- |
|
| Mccormack Robert S |
SVP Gen Counsel & Corp Sec |
• – – |
2023-03-02 |
4 |
D |
$4.25 |
$159,345 |
D/D |
(37,493) |
491,000 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2023-03-02 |
4 |
D |
$4.25 |
$158,614 |
D/D |
(37,321) |
4,116,365 |
|
- |
|
| Ziegler Paul Jr |
Chief Commercial Officer |
• – – |
2023-03-02 |
4 |
D |
$4.25 |
$76,925 |
D/D |
(18,100) |
402,196 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
D |
$4.12 |
$142,148 |
D/D |
(34,502) |
694,068 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
86,405 |
728,570 |
|
- |
|
| Mccormack Robert S |
SVP Gen Counsel & Corp Sec |
• – – |
2023-03-01 |
4 |
D |
$4.34 |
$129,636 |
D/D |
(29,870) |
528,493 |
|
- |
|
| Mccormack Robert S |
SVP Gen Counsel & Corp Sec |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
86,405 |
558,363 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2023-03-01 |
4 |
D |
$4.34 |
$672,474 |
D/D |
(154,948) |
4,153,686 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
483,870 |
4,308,634 |
|
- |
|
| Ziegler Paul Jr |
Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
D |
$4.34 |
$122,401 |
D/D |
(28,203) |
420,296 |
|
- |
|
| Ziegler Paul Jr |
Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
115,207 |
448,499 |
|
- |
|
| Burke Willaim P |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
103,686 |
356,318 |
|
- |
|
| Burke Willaim P |
Chief Financial Officer |
• – – |
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
252,632 |
252,632 |
|
- |
|
| Schnabel Susan C |
Director |
– • – |
2023-01-03 |
4 |
A |
$4.40 |
$48,000 |
D/D |
10,909 |
203,699 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2023-01-03 |
4 |
A |
$4.40 |
$72,996 |
D/D |
16,590 |
898,477 |
|
- |
|
| Spencer Phillip M |
Director |
– • – |
2023-01-03 |
4 |
A |
$4.40 |
$55,999 |
D/D |
12,727 |
155,029 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2023-01-03 |
4 |
A |
$4.40 |
$55,999 |
D/D |
12,727 |
210,393 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2023-01-03 |
4 |
A |
$4.40 |
$115,997 |
D/D |
26,363 |
353,872 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2023-01-03 |
4 |
D |
$4.40 |
$424,802 |
D/D |
(96,546) |
3,824,764 |
|
- |
|
| Schnabel Susan C |
Director |
– • – |
2022-11-28 |
4 |
B |
$4.68 |
$117,410 |
D/D |
25,000 |
192,790 |
2.39 |
-32% |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2022-10-24 |
4 |
D |
$4.30 |
$162,028 |
D/D |
(37,681) |
642,165 |
|
- |
|
318 Records found
|
|
Page 2 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
